Kolexia
Ebel Bitoun Caty
Médecine générale
Sanofi
Lieu inconnu
17 Activités
131 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Dorsalgie Douleur aigüe Cervicalgie Vessie hyperactive Céphalée Migraines Incontinence urinaire Arthrose Lombalgie

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Paracetamol Use in Patients With Osteoarthritis and Lower Back Pain: Infodemiology Study and Observational Analysis of Electronic Medical Record Data.
JMIR public health and surveillance   27 octobre 2022
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine.
Pain and therapy   07 décembre 2021
Multinational descriptive analysis of the real-world burden of headache using the Migraine Buddy application.
European journal of neurology   26 juillet 2021
21st century headache: mapping new territory.
The journal of headache and pain   01 avril 2021
Efficacy and Safety of Diclofenac + Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study.
Pain and therapy   27 mars 2020
A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain.
Journal of pain research   23 septembre 2019
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain: A Randomized, Controlled Multi-centre Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of a Topically Applied Combination Containing Diclofenac 2% + Capsaicin 0.075% (2 g Formulation Per Application; 2-times Daily for 5 Days) Compared to Placebo, as Well as to Diclofenac 2% and Capsaicin 0.075% in Patients With Acute Back or Neck Pain
Essai Clinique (Boehringer Ingelheim)   05 février 2019
Effects of drug cessation after flexible-dose fesoterodine in patients with overactive bladder.
BJU international   07 mars 2013
Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation.
International urogynecology journal   11 mai 2012
71 TYPES OF URINARY INCONTINENCE AND BODY MASS INDEX: RESULTS FROM EPILUTS
AUA Annual Meeting Program Abstracts 2012   01 avril 2012